170 related articles for article (PubMed ID: 21477999)
1. Lamellar crystalline self-assembly behaviour and solid lipid nanoparticles of a palmityl prodrug analogue of Capecitabine--a chemotherapy agent.
Gong X; Moghaddam MJ; Sagnella SM; Conn CE; Danon SJ; Waddington LJ; Drummond CJ
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):349-59. PubMed ID: 21477999
[TBL] [Abstract][Full Text] [Related]
2. Lyotropic liquid crystalline self-assembly material behavior and nanoparticulate dispersions of a phytanyl pro-drug analogue of capecitabine-a chemotherapy agent.
Gong X; Moghaddam MJ; Sagnella SM; Conn CE; Danon SJ; Waddington LJ; Drummond CJ
ACS Appl Mater Interfaces; 2011 May; 3(5):1552-61. PubMed ID: 21446773
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured nanoparticles of self-assembled lipid pro-drugs as a route to improved chemotherapeutic agents.
Sagnella SM; Gong X; Moghaddam MJ; Conn CE; Kimpton K; Waddington LJ; Krodkiewska I; Drummond CJ
Nanoscale; 2011 Mar; 3(3):919-24. PubMed ID: 21173998
[TBL] [Abstract][Full Text] [Related]
4. Endogenous nonionic saturated monoethanolamide lipids: solid state, lyotropic liquid crystalline, and solid lipid nanoparticle dispersion behavior.
Sagnella SM; Conn CE; Krodkiewska I; Moghaddam M; Drummond CJ
J Phys Chem B; 2010 Feb; 114(4):1729-37. PubMed ID: 20063872
[TBL] [Abstract][Full Text] [Related]
5. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
7. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
8. Knowledge-Based Design of 5-Fluororacil Prodrug Liposomal Formulation: Molecular Packing and Interaction Revealed by Interfacial Isotherms and X-ray Scattering Techniques.
Pham T; Plata PL; Zhang P; Vellara A; Bu W; Lin B; Cheng G; Liu Y
Mol Pharm; 2021 Dec; 18(12):4331-4340. PubMed ID: 34739257
[TBL] [Abstract][Full Text] [Related]
9. Nanostructured nonionic thymidine nucleolipid self-assembly materials.
Mulet X; Kaasgaard T; Conn CE; Waddington LJ; Kennedy DF; Weerawardena A; Drummond CJ
Langmuir; 2010 Dec; 26(23):18415-23. PubMed ID: 21058676
[TBL] [Abstract][Full Text] [Related]
10. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
11. Solvent injection-lyophilization of tert-butyl alcohol/water cosolvent systems for the preparation of drug-loaded solid lipid nanoparticles.
Wang T; Wang N; Zhang Y; Shen W; Gao X; Li T
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):254-61. PubMed ID: 20447810
[TBL] [Abstract][Full Text] [Related]
12. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
Das S; Ng WK; Kanaujia P; Kim S; Tan RB
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
[TBL] [Abstract][Full Text] [Related]
13. Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles.
Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
J Microencapsul; 2009 Dec; 26(8):734-47. PubMed ID: 19888882
[TBL] [Abstract][Full Text] [Related]
14. The thermotropic phase behaviour and phase structure of a homologous series of racemic beta-D-galactosyl dialkylglycerols studied by differential scanning calorimetry and X-ray diffraction.
Mannock DA; Collins MD; Kreichbaum M; Harper PE; Gruner SM; McElhaney RN
Chem Phys Lipids; 2007 Jul; 148(1):26-50. PubMed ID: 17524381
[TBL] [Abstract][Full Text] [Related]
15. Plasmin-activated doxorubicin prodrugs containing a spacer reduce tumor growth and angiogenesis without systemic toxicity.
Devy L; de Groot FM; Blacher S; Hajitou A; Beusker PH; Scheeren HW; Foidart JM; Noël A
FASEB J; 2004 Mar; 18(3):565-7. PubMed ID: 14734647
[TBL] [Abstract][Full Text] [Related]
16. Ordering of lipid A-monophosphate clusters in aqueous solutions.
Faunce CA; Reichelt H; Quitschau P; Paradies HH
J Chem Phys; 2007 Sep; 127(11):115103. PubMed ID: 17887884
[TBL] [Abstract][Full Text] [Related]
17. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility.
Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D
J Microencapsul; 2011; 28(1):74-81. PubMed ID: 21171818
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism and possible biochemical modulation of capecitabine (Xeloda), a newly generated oral fluoropyrimidine].
Saeki T; Takashima S
Gan To Kagaku Ryoho; 1999 Mar; 26(4):447-55. PubMed ID: 10097741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
